A proton magnetic resonance spectroscopic study in ALS
- 1 October 1998
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 51 (4) , 1104-1109
- https://doi.org/10.1212/wnl.51.4.1104
Abstract
Objective: To evaluate neuronal dysfunction in the motor region subcortical white matter in ALS using volumetric localized proton magnetic resonance spectroscopy (1H-MRS). Methods: Sixteen patients with El Escorial definite, probable, or possible ALS and eight healthy age-matched control subjects were studied. The ALS patients were divided into those with limb onset (n = 8) and those with bulbar onset (n = 8). Measurements of the metabolic ratios N-acetylaspartate (NAA)/creatine and phosphocreatine (Cr+PCr), NAA/choline (Cho), and Cho/(Cr+PCr) were correlated with clinical assessments. Results: We found no differences in the metabolic peak area ratios in the motor region when comparing the total ALS group and the control subjects. However, correlations were found between the NAA/(Cr+PCr) ratio and the El Escorial category (p = 0.03), the ALS severity scale (p = 0.01), and the Medical Research Council score (p = 0.06). No correlations were found between the NAA/(Cr+PCr) ratio and the Ashworth Spasticity Scale, reflex score, or disease duration (p > 0.16). Bulbar-onset patients had a lower NAA/(Cr+PCr) ratio in the motor region compared with limb-onset patients (p = 0.03). Conclusion: In vivo 1H-MRS of the subcortical white matter in the motor region is unlikely to be sensitive enough to detect early disease changes in ALS because there is considerable overlap between the metabolic peak area ratios from patients with ALS and normal control subjects. However, changes in the NAA/(Cr+PCr) metabolic peak area ratios correlate with clinical measures of disease severity, and this measure may be useful in monitoring disease progression.Keywords
This publication has 9 references indexed in Scilit:
- Attitudes of US neurologists concerning the ethical dimensions of managed careNeurology, 1997
- Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amytrophic lateral sclerosis)Journal of the Neurological Sciences, 1995
- Regional Metabolic Assessment of Human Brain during Development by Proton Magnetic Resonance Spectroscopy In Vivo and by High-Performance Liquid Chromatography/Gas Chromatography in Autopsy TissuePediatric Research, 1995
- El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosisJournal of the Neurological Sciences, 1994
- Megadose corticosteroids in multiple sclerosisNeurology, 1994
- In Vivo Proton Spectroscopy. Experimental Aspects and PotentialPublished by Springer Nature ,1992
- Regional distribution of thrombomodulin in human brainBrain Research, 1991
- Rapid diagnosis of tuberculous meningitis by polymerase chain reactionThe Lancet, 1991
- Declining Trends in Mortaliy from Cerebrovascular Disease at Ages 10–65 Years: A Test of ValidityNeuroepidemiology, 1988